Covered recipient · General Payments record
JONATHAN M JOLIAT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$6,410.50
- Reported across 293 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $766.45 | 13 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $258.46 | 3 |
| Novo Nordisk AS | $232.77 | 4 |
| Amgen Inc. | $152.15 | 3 |
| Lilly USA, LLC | $90.10 | 1 |
| Astellas Pharma US Inc | $32.97 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (13)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $123.72 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117590711 | CMS |
| Amgen Inc. | $15.06 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117289777 | CMS |
| Amgen Inc. | $13.37 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117289779 | CMS |
| Astellas Pharma US Inc | $16.37 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139341262 | CMS |
| Astellas Pharma US Inc | $16.60 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139394829 | CMS |
| AstraZeneca Pharmaceuticals LP | $124.74 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104698372 | CMS |
| AstraZeneca Pharmaceuticals LP | $121.84 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104429829 | CMS |
| AstraZeneca Pharmaceuticals LP | $11.88 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104581810 | CMS |
| Lilly USA, LLC | $90.10 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135078439 | CMS |
| Novo Nordisk Inc | $96.88 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096772777 | CMS |
| Novo Nordisk Inc | $13.76 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096960526 | CMS |
| Novo Nordisk Inc | $15.03 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097594636 | CMS |
| Novo Nordisk Inc | $107.10 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096969503 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.